Published online October 1, 2004
PEDIATRICS Vol. 114 No. 4 October 2004, pp. e523-e526 (doi:10.1542/peds.2004-0198)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McBride, K. L.
Right arrow Articles by Lee, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McBride, K. L.
Right arrow Articles by Lee, B.
Related Collections
Right arrow Nutrition & Metabolism

ELECTRONIC ARTICLE

Developmental Outcomes With Early Orthotopic Liver Transplantation for Infants With Neonatal-Onset Urea Cycle Defects and a Female Patient With Late-Onset Ornithine Transcarbamylase Deficiency

Kim L. McBride, MD*, Geoffrey Miller, MD{ddagger}, Susan Carter, BSN*,||, Saul Karpen, MD, PhD{ddagger}, John Goss, MD§ and Brendan Lee, MD, PhD*,||

* Molecular and Human Genetics
{ddagger} Pediatrics
§ Surgery
|| Howard Hughes Medical Institute, Baylor College of Medicine, Houston, Texas

Urea cycle defects (UCDs) typically present with hyperammonemia, the duration and peak levels of which are directly related to the neurologic outcome. Liver transplantation can cure the underlying defect for some conditions, but the preexisting neurologic status is a major factor in the final outcome. Multicenter data indicate that most of the children who receive transplants remain significantly neurologically impaired. We wanted to determine whether aggressive metabolic management of ammonia levels after early referral/transfer to a metabolism center and early liver transplantation would result in better neurologic outcomes. We report on 5 children with UCDs, ie, 2 male patients with X-linked ornithine transcarbamylase deficiency and 2 male patients with carbamoyl phosphate synthase deficiency, all of whom had neonatal presentations and underwent orthotopic liver transplantation before 1 year of age, and 1 female patient with partial X-linked ornithine transcarbamylase deficiency that was intractable to medical therapy, who underwent transplantation at 35 months of age. Developmental testing with the Griffiths scale was performed on 3 occasions each, 12 months apart, up to 45 months after transplantation. Full-scale indices for 3 children who underwent early transplantation showed average developmental quotients of 67. All 5 children had metabolic cures. There were no deaths (30-month survival rate: 100%). One child is currently listed for repeat transplantation because of bile duct stenosis and cirrhosis. We conclude that early liver transplantation and aggressive metabolic management improve early neurologic outcomes for children with UCDs, but longer follow-up monitoring is needed.

Key Words: urea cycle defect • liver transplantation • ornithine transcarbamylase deficiency • development • outcome

Abbreviations: UCD, urea cycle defect • CPS, carbamoyl phosphate synthase • OTC, ornithine transcarbamylase • EBV, Epstein-Barr virus • OLT, orthotopic liver transplantation

Accepted May 13, 2004.




This article has been cited by other articles:


Home page
 NEJMHome page
G. M. Enns, S. A. Berry, G. T. Berry, W. J. Rhead, S. W. Brusilow, and A. Hamosh
Survival after Treatment with Phenylacetate and Benzoate for Urea-Cycle Disorders
N. Engl. J. Med., May 31, 2007; 356(22): 2282 - 2292.
[Abstract] [Full Text] [PDF]